MedTrace Logo

Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers

NCT02329353 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-01-10

No results posted yet for this study

Summary

Periodontitis is one of the most common chronic inflammatory disease with the etiology of bacterial plaque and is associated with a number of putative bacterial species. The periodontal destruction is substantially mediated by the host, driven by the bacterial challenge. The presence of pathogenic bacteria with the absence of so-called "beneficial bacteria" and the susceptibility of the host are the main aetiological factors of periodontal diseases.

Conditions

  • Chronic Periodontitis

Interventions

DRUG

Lactobacillus brevis CD2 Lozenges

Each lozenge contains not less than 1 billion Colony forming unit of Lactobacillus brevis CD2

Sponsors & Collaborators

  • Krishnadevaraya College of Dental Sciences & Hospital

    collaborator OTHER

  • Next Gen Pharma India Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Rudrakshi chickanna, MDS · KRISHNADEVARAYA COLLEGE OF DENTAL SCIENCES AND HOSPITAL, BANGALORE

  • Shruthi J R, BDS · KRISHNADEVARAYA COLLEGE OF DENTAL SCIENCES AND HOSPITAL, BANGALORE

  • Prabhuji MLV, MDS · KRISHNADEVARAYA COLLEGE OF DENTAL SCIENCES AND HOSPITAL, BANGALORE

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-11-30
Completion
2016-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02329353 on ClinicalTrials.gov